1. Home
  2. Live Updates
  3. Squamous carcinoma

Live Breaking News & Updates on Squamous carcinoma

Stay informed with the latest breaking news from Squamous carcinoma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Squamous carcinoma and stay connected to the pulse of your community

Less Than 50% of Accelerated Approvals Show Clinical Benefit

A new study looks at 5-year outcomes of cancer drugs that were given accelerated approvals.

Australia , Boston , Massachusetts , United-states , Portland , Oregon , Melbourne , Victoria , American , Shivaani-kummar , Edward-cliff , Us-congress

Improve Your Dx of This Oft-Missed Genital Disorder

The nonspecific symptoms of lichen sclerosus often lead to a missed or delayed diagnosis, exacerbating the challenges that patients with the condition face.

Irvine , California , United-states , Nebraska , University-of-california-san-francisco , Christina-kraus , Los-angeles , Benjaminn-breyer , Sarah-lonowski , University-of-nebraska , Health-in-irvine , Us-national-institutes-of-health

Lifetime Cost of DEB Gene Therapy Could Be $15-$22 Million

The most expensive gene therapy on the US market may give payers pause, said study authors.

Boston , Massachusetts , United-states , Adamjn-raymakers , Liz-fowler , Department-of-dermatology , Division-of-pulmonary , Drug-administration , Program-on-regulation , Innovation-center , Krystal-biotech , Critical-care-medicine

The right to die is about human dignity

Last Wednesday, Carol de Swardt died peacefully at Pegasos Clinic in Liestal, Switzerland.

Switzerland , Last-wednesday , Carol-de-swardt , Pegasos-clinic , Leratong-hospital , Euthanasia , Pegasos-clinic-in-liestal , George , Cancer , Squamous-carcinoma , Leg-amputation

AI-Powered Device Cleared as Noninvasive Skin Cancer Test

The handheld tool, intended for use by primary care physicians, uses spectroscopy and algorithms to evaluate skin lesions for potential cancer in a matter of seconds.

Australia , United-states , Armandb-cognetta-jr , Dermasensor-inc , Drug-administration , Miami-based-dermasensor-inc , Skin-cancer , Alignant-skin-neoplasm , Cancer , Alignant-neoplasia , Arcinoma

Checkpoint Therapeutics Slides After US FDA Declines Cancer Therapy Approval

Checkpoint Therapeutics said on Monday the U.S. Food and Drug Administration had declined to approve its experimental therapy to treat a form of skin cancer following an...

Waltham , Massachusetts , United-states , Bengaluru , Karnataka , India , Sriraj-kalluvila , Pooja-desai , Puyaan-singh , Reuters , Drug-administration , Checkpoint-therapeutics

Replimune Skin Cancer Therapy Fails Midstage Study

Replimune Group said on Tuesday its experimental combination therapy to treat a common form of skin cancer failed to significantly remove or reduce cancerous lesions in a midstage study.

Massachusetts , United-states , Bengaluru , Karnataka , India , Evan-seigerman , Arun-koyyur , Puyaan-singh , Sriraj-kalluvila , Reuters , Replimune-group , Mariam-sunny

Choosing the Right Approach to Cancer and Menopause Symptoms

Hormone replacement therapy may be considered to lessen these symptoms, but only in certain conditions, said a gynecologist.

Australia , Paris , France-general- , France , Melbourne , Victoria , Martha-hickey , Obstetric-congress , University-of-melbourne , Menopause , Enopausal-syndrome , Breast-cancer

Actinic Keratoses May Predict Skin Cancers in Older Adults

A retrospective cohort study showed increased absolute and relative risks for skin cancers up to 5 years after an AK diagnosis.

Texas , United-states , Houston , University-of-texas , Cassandra-mohr , Mackenzier-wehner , University-of-texas-md-anderson-cancer-center , University-of-texas-rising , Research-institute-of-texas , Cancer-center , National-cancer-institute , National-institutes

ADC Shows Survival Benefit in Mets Cervical Cancer

The antibody-drug conjugate tisotumab vedotin led to improved outcomes compared with chemotherapy in second- or third-line treatment of recurrent/metastatic cervical cancer.

California , United-states , Irvine , Krishnansu-tewari , European-society-of-medical-oncology , University-of-california , Astrazeneca , European-society , Medical-oncology , Cervical-cancer , Alignant-cervix-neoplasm , Chemotherapy